[IMS-SA-07] Morning Seminar 7: Panel Discussion on Ocular Infection Strategies - Insight from a Comparison of the Current Situation in Japan and the US -
- Apr 05 (Sat)
- 07:30 - 08:30
- Room 5 - Tokyo International Forum 7F Hall D7
- SENJU PHARMACEUTICAL CO.,LTD.
- Ocular Inflammation,Infection, Uvea
- Chair）Yoshitsugu Inoue
- The treatment and prevention of ocular infection is different between countries. For instance, conjunctivitis due to quinolone-resistant Corynebacterium spp. is a Japan-specific phenomenon, probably due to a 90% share of fluoroquinolones in antibiotic eye drops. Pre-operative povidone-iodine is used as 5% in eye drops in theUS, and as 0.625% in eye wash in Japan. In this seminar, Dr. O’Brien will present the treatment of conjunctivitis and the prevention of postoperative endophthalmitisin the US, and Dr. Hatano will present the treatment of conjunctivitis in Japan, and I will present the prevention of postoperative endophthalmitis in Japan. The implications derived from the comparison of the strategies against ocular infection in both countries will be discussed.